Home Cart Sign in  
Chemical Structure| 31230-17-8 Chemical Structure| 31230-17-8
Chemical Structure| 31230-17-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 3-Amino-5-methylpyrazole

CAS No. :31230-17-8
Formula : C4H7N3
M.W : 97.12
SMILES Code : NC1=NNC(C)=C1
MDL No. :MFCD00075180
InChI Key :FYTLHYRDGXRYEY-UHFFFAOYSA-N
Pubchem ID :93146

Safety of 3-Amino-5-methylpyrazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P305+P351+P338

Application In Synthesis of 3-Amino-5-methylpyrazole

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 31230-17-8 ]
  • Downstream synthetic route of [ 31230-17-8 ]

[ 31230-17-8 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 31230-17-8 ]
  • [ 57097-81-1 ]
YieldReaction ConditionsOperation in experiment
62% With hydrogen bromide; copper(I) bromide; sodium nitrite In water at 70℃; for 0.5 h; S2. 1.9 g of 3-amino-5-methylpyrazole (2),15mL concentrated hydrobromic acid,2.8g cuprous bromide mixed into 100mL three-necked flask,Heated to 70 ;Take about 1.5g sodium nitrite dissolved in 5mL water,Using a constant pressure funnel slowly dropping into a three-necked flask;After the addition is completed,The reaction solution was stirred at 70 for 30min,After cooling to room temperature, 20 mL THF was added,20mL water;The mixture was extracted three times with 30 mL of ether, the organic layer was washed with sodium thiosulfate solution, dried over magnesium sulfate, filtered through silica gel,The solvent was distilled off under reduced pressure to give 3-methyl-5-bromopyrazole (3) in a yield of 62percent;
52% at 70℃; for 0.5 h; 1.9 g of 3-amino-5-methylpyrazole (19), 15 mL of concentrated hydrobromic acid, and 2.8 g of cuprous bromide were placed in a 100 mL three-necked flask and heated to 70 °C.Approximately 1.5 g of sodium nitrite was dissolved in 5 mL of water and slowly added dropwise to a three-necked flask using a constant pressure funnel.After the completion of the addition, the reaction solution was stirred at 70 ° C for 30 min, then cooled to room temperature, and 20 mL of THF (tetrahydrofuran) and 20 mL of water were added.It was extracted three times with 30 mL of diethyl ether. The organic layer was washed with sodium thiosulfate solution and dried over magnesium sulfate.After filtration with silica gel, the solvent was evaporated under reduced pressure to give 1.7 g of 3-methyl-5-bromopyrazole (20) in a yield of 52percent.
References: [1] Patent: CN104844567, 2017, B, . Location in patent: Paragraph 0031; 0035; 0040; 0045.
[2] Patent: CN108191822, 2018, A, . Location in patent: Paragraph 0059; 0060; 0061.
  • 2
  • [ 31230-17-8 ]
  • [ 1229236-86-5 ]
YieldReaction ConditionsOperation in experiment
22%
Stage #1: With sodium hydrogencarbonate In N,N-dimethyl-formamide at 150℃; for 1 h;
Stage #2: With hydrogenchloride In 2-methyltetrahydrofuran; water
Stage #3: With sodium hydroxide In butan-1-ol
Prepare active catalyst by combining palladium chloride (160 mg, 0.90 mmol) and 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (1.10 g, 1.84 mmol) in DMF (25 mL) and warming to form a solution. Add the preformed catalyst to a solution of 3-methyl-1H-pyrazol-5-amine (3.0 g, 29.65 mmol), 4-((6-chloro-3-(4-chloro-2-fluorobenzyl)-2-methylimidazo[1,2-b]pyridazin-8-yl)methyl)morpholine hydrochloride (9.0 g, 20.19 mmol), potassium bicarbonate (6.0 g, 59.93 mmol) in DMF (65 mL) and heat to 150° C. for 1 h. Cool the reaction to 60° C. and add mercaptopropyl functionalized silica (500 mg) and stir for 1 h then filter to remove the silica. Cool to ambient temperature, add 2-methyltetrahydrofuran (125 mL) and extract with water to remove DMF. Add HCl to the organic solution to form the 3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine hydrochloride salt. Add the HCl salt (1.1 g) to sodium hydroxide (10 mL, 1N) in n-butanol (10 mL) and stir. Filter the resulting mixture to obtain 0.22 g of the free base, imidazo[1,2-b]pyridazin-6-amine, 3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl), (22percent yield, M+1.=470).
References: [1] Patent: US2010/152181, 2010, A1, . Location in patent: Page/Page column 5.
 

Historical Records

Technical Information

Categories